Terabe, M., Robertson, F. C., Clark, K., De Ravin, E., Bloom, A., Venzon, D. J., . . . Berzofsky, J. A. (2017). Blockade of only TGF-β 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy. Oncoimmunology.
シカゴスタイル引用形Terabe, Masaki, Faith C. Robertson, Katharine Clark, Emma De Ravin, Anja Bloom, David J. Venzon, Shingo Kato, Amer Mirza, , Jay A. Berzofsky. "Blockade of Only TGF-β 1 and 2 Is Sufficient to Enhance the Efficacy of Vaccine and PD-1 Checkpoint Blockade Immunotherapy." Oncoimmunology 2017.
MLA引用形式Terabe, Masaki, et al. "Blockade of Only TGF-β 1 and 2 Is Sufficient to Enhance the Efficacy of Vaccine and PD-1 Checkpoint Blockade Immunotherapy." Oncoimmunology 2017.